Biocells (Beijing) Biotech Co.,Ltd
2 clinical trials · Sponsor
◉ Watch Biocells (Beijing) Biotech Co.,Ltd
| Record | Firm | Date |
|---|---|---|
| A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. (NCT07520565) | Biocells (Beijing) Biotech Co.,Ltd | 2026-01-19 |
| BXOS110 Injection in the Treatment of Acute Ischaemic Stroke (NCT06322394) | Biocells (Beijing) Biotech Co.,Ltd | 2024-02-07 |
Track Biocells (Beijing) Biotech Co.,Ltd automatically
Every clearance here is in the API, with alerts when new ones post.